Is Participation in Cancer Phase I Trials Really Therapeutic?
- PMID: 27646944
- PMCID: PMC5321666
- DOI: 10.1200/JCO.2016.67.9902
Is Participation in Cancer Phase I Trials Really Therapeutic?
Conflict of interest statement
Comment in
-
Reaffirming and Clarifying the American Society of Clinical Oncology's Policy Statement on the Critical Role of Phase I Trials in Cancer Research and Treatment.J Clin Oncol. 2017 Jan 10;35(2):139-140. doi: 10.1200/JCO.2016.70.4692. Epub 2016 Nov 28. J Clin Oncol. 2017. PMID: 27893329 Free PMC article. No abstract available.
-
A Rationale for Relaxing the Requirement to Undergo a Noncurative Chemotherapy for Advanced Cancer in a Phase I Immunotherapy Trial.Am J Bioeth. 2017 Apr;17(4):68-69. doi: 10.1080/15265161.2017.1284922. Am J Bioeth. 2017. PMID: 28328363 No abstract available.
References
-
- Miller FG, Joffe S. Benefit in phase I oncology trials: therapeutic misconception or reasonable treatment option? Clin Trials. 2008;5:617–23. - PubMed
-
- Schüklenk U, Lowry C. Terminal illness and access to phase I experimental agents, surgeries and devices: reviewing the ethical arguments. Br Med Bull. 2009;89:7–22. - PubMed
-
- Ross L. Phase I research and the meaning of direct benefit. J Pediatr. 2006;149:S20–4. - PubMed
-
- Miller M. Phase I cancer trials. A collusion of misunderstanding. Hastings Cent Rep. 2000;30:34–43. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
